SER•benzinga•
Serina Therapeutics Announces Closing Of $5M Financing From Shareholders, Proceeds Will Be Used To Support Advancement Of SER-252 Into Clinical Development For Advanced Parkinson's Disease
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 8, 2025 by benzinga